green tick

PBAC ramps up biosimilar drive

PBAC ramps up biosimilar drive

It says pharmacists should be allowed to substitute Remicade with Inflectra, sparking criticism from Medicines Australia

Preventable liver transplants soar in Australia and NZ

Preventable liver transplants soar in Australia and NZ

And non-alcoholic fatty liver disease is a ‘burgeoning epidemic’, report Melbourne researchers

Study pinpoints childhood factors in IBS

Study pinpoints childhood factors in IBS

But its findings do not support the so-called ‘hygiene hypothesis’

Closing in on Helicobacter Pylori

Closing in on Helicobacter Pylori

A panel of experts have voted to include it in the ICD-11 classification system

Gastroenterologists raise concerns over biosimilars

Gastroenterologists raise concerns over biosimilars

Apart from one highly specific exception, there is not enough data to justify a switch away from an originator molecule

PBAC ramps up biosimilar drive

PBAC ramps up biosimilar drive

0

It says pharmacists should be allowed to substitute Remicade with Inflectra, sparking criticism from Medicines Australia

view more

Fructose, lactose and a low FODMAP diet

Fructose, lactose and a low FODMAP diet

There is now substantial evidence to confirm the efficacy of a low FODMAP diet in at least 70% of IBS patients in Australia and internationally

Placebo effects in trials … the blind leading the not so blind

Placebo effects in trials … the blind leading the not so blind

When blinding performance is not reported, researchers and health professionals have no way of assessing whether the placebo effect may have biased a trial

view more

 Subscribe to the Newsletter


 Breaking medical news
 A daily must-read for doctors
 Delivered to your inbox
Advertisement
Advertisement
Advertisement
My list
  •  
Read Later